![]() |
Name |
4-Penten-2-one, 4-methyl-
|
Molecular Formula | C6H10O | |
IUPAC Name* |
4-methylpent-4-en-2-one
|
|
SMILES |
CC(=C)CC(=O)C
|
|
InChI |
InChI=1S/C6H10O/c1-5(2)4-6(3)7/h1,4H2,2-3H3
|
|
InChIKey |
VADUDTKCGJKNDY-UHFFFAOYSA-N
|
|
Synonyms |
4-Penten-2-one, 4-methyl-; 4-methylpent-4-en-2-one; 4-Methyl-4-penten-2-one; 3744-02-3; ISOMESITYL OXIDE; Isopropenyl acetone; P549RW6459; Isopropenylacetone; 3-Acetylisobutene; 2-Methylene-4-pentanal; 4-methyl-pent-4-en-2-one; DTXSID4073966; UNII-P549RW6459; CHEBI:173332; CH3C(O)CH2C(CH3)=CH2; AKOS017516565; AI3-24338; E77682; EN300-1856366; Q27286189
|
|
CAS | 3744-02-3 | |
PubChem CID | 19543 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 98.14 | ALogp: | 1.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 7 | QED Weighted: | 0.483 |
Caco-2 Permeability: | -4.293 | MDCK Permeability: | 0.00002730 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.09 |
30% Bioavailability (F30%): | 0.013 |
Blood-Brain-Barrier Penetration (BBB): | 0.984 | Plasma Protein Binding (PPB): | 60.12% |
Volume Distribution (VD): | 1.518 | Fu: | 56.54% |
CYP1A2-inhibitor: | 0.496 | CYP1A2-substrate: | 0.557 |
CYP2C19-inhibitor: | 0.273 | CYP2C19-substrate: | 0.873 |
CYP2C9-inhibitor: | 0.046 | CYP2C9-substrate: | 0.241 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.434 |
CYP3A4-inhibitor: | 0.006 | CYP3A4-substrate: | 0.419 |
Clearance (CL): | 7.976 | Half-life (T1/2): | 0.851 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.134 |
Drug-inuced Liver Injury (DILI): | 0.078 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.038 | Maximum Recommended Daily Dose: | 0.343 |
Skin Sensitization: | 0.922 | Carcinogencity: | 0.79 |
Eye Corrosion: | 0.994 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.479 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001203 | ![]() |
0.345 | D0Z4NI | ![]() |
0.308 | ||
ENC000288 | ![]() |
0.333 | D0F1GS | ![]() |
0.308 | ||
ENC005488 | ![]() |
0.308 | D04CRL | ![]() |
0.250 | ||
ENC000418 | ![]() |
0.308 | D0G4JI | ![]() |
0.250 | ||
ENC000237 | ![]() |
0.308 | D0C1PY | ![]() |
0.238 | ||
ENC000313 | ![]() |
0.308 | D0Z4UY | ![]() |
0.238 | ||
ENC004974 | ![]() |
0.282 | D0ZK8H | ![]() |
0.233 | ||
ENC000453 | ![]() |
0.280 | D0R9BG | ![]() |
0.217 | ||
ENC000312 | ![]() |
0.280 | D06XGW | ![]() |
0.200 | ||
ENC000225 | ![]() |
0.276 | D0XB8P | ![]() |
0.200 |